29. Уэлборн Т. и другие. Оригинальная публикация: Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet. 1966; 1(7451): 1336–1337.
30. Ферраннини E. и другие. Оригинальная публикация: Insulin resistance, hyperinsulinemia, and blood pressure. Role of age and obesity. Hypertension. 1997; 30(5): 1144–1149.
31. Парк С. и другие. Оригинальная публикация: Impact of hyperinsulinemia on the development of hypertension in normotensive, nondiabetic adults: a 4-year follow-up study. Metabolism. 2013 Apr; 62(4): 532–538.
32. Сюн П. и другие. Оригинальная публикация: Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies. Am J Clin Nutr. 2013; 98(6): 1543–1554.
33. Крситлиб Р. и другие. Оригинальная публикация: Is insulin the link between hypertension and obesity? Hypertension. 1985; 7(Suppl II): II-54–II-57; Excess exposure to insulin is the primary cause of insulin resistance and its associated atherosclerosis. Curr Mol Pharmacol. 2011; 4(3): 154–166.
34. Рейкер Р. и другие. Оригинальная публикация: Positive inotropic action of insulin on piglet heart. Yale. J. Biol. Med., 1975; 48: 353–360.
35. Бьоннер Г. Оригинальная публикация: Hyperinsulinemia, insulin resistance, and hypertension. J Cardiovasc Pharmacol. 1994; 24(Suppl 2): S39–49.
36. Саттар Н. и другие. Оригинальная публикация: Serial metabolic measurements and conversion to type 2 diabetes in the West of Scotland Coronary Prevention Study. Diabetes. 2007; 56(4): 984–991.
37. Колата Г. Оригинальная публикация: Skinny and 119 pounds, but with the health hallmarks of obesity. New York Times. 2016 July 22. Адрес ссылки: https://www.nytimes. com/2016/07/26/ health/skinny-fat.html?mcubz=3
Глава 10
1. Геллер А. и другие. Оригинальная публикация: National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Intern Med. 2014 May; 174(5): 678–686.
2. Оригинальная публикация: The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14): 977–986.
3. Оригинальная публикация: The DCCT/EDIC Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005; 353(25): 2643–2653.
4. На основе данных, полученных от The Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial. Diabetes Care. 2001 Oct; 24(10): 1711–1721.
5. Пернелл Дж. и другие. Оригинальная публикация: The effect of excess weight gain with intensive diabetes treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes: Results from the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study. Circulation. 2013 January 15; 127(2): 180–187. doi: 10.1161/CIRCULATIONAHA.111.077487. Доступ 2017 июнь 6.
6. Миус М. Оригинальная публикация: High cumulative insulin exposure: a risk factor of atherosclerosis in type 1 diabetes? Atherosclerosis. 2005 Jul; 181(1): 185–192.
7. Оригинальная публикация: UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998 Sep 12; 352(9131): 837-53.
8. Оригинальная публикация: UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998 Sep 12; 352(9131): 854-865.
9. Розен С. и другие. Оригинальная публикация: The rosiglitazone story—lessons from an FDA Advisory Committee Meeting. N Engl J Med. 2007; 357(9): 844–846.
10. Оригинальная публикация: The ACCORD Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008 Jun 12; 358(24): 2545–2559.
11. Оригинальная публикация: The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 358(24): 2560–2572.
12. Дакворт У. и другие. Оригинальная публикация: Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009; 360(2): 129–139.
13. Оригинальная публикация: The ORIGIN Trial Investigators. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med. 2012; 367(4): 319–328.
14. Оригинальная публикация: The ACCORD Study Group. Long-term effects of intensive glucose lowering on cardiovascular outcome. N Engl J Med. 2011; 364(9): 818–828; Hayward R. A. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015; 372(23): 2197–2206; Zoungas S. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med. 2014; 371(15): 1392–1406.
15. Кинг П. и другие. Оригинальная публикация: The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999; 48(5): 643–648.
16. Соедама-Мутху С. и другие. Оригинальная публикация: Relationship between risk factors and mortality in type 1 diabetic patients in Europe. The EURODIAB Prospective Complications Study (PCS). Diabetes Care. 2008; 31(7): 1360–1366.
17. Байн С. и другие. Оригинальная публикация: Characteristics of type 1 diabetes of over 50 years duration (the Golden Years Cohort). Diabetic Medicine. 2003; 20(10): 808–811.
18. Крофтс К. и другие. Оригинальная публикация: Hyperinsulinemia: a unifying theory of chronic disease? Diabesity. 2015; 1(4): 34–43; 41. Meinert C. L. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes. 1970; 19(Suppl): 789–830.
19. Юдкин Дж. и другие. Оригинальная публикация: Intensified glucose lowering in type 2 diabetes: time for a reappraisal. Diabetologia. 2010 Oct; 53(10): 2079–2085.
20. Прадан Д. и другие. Оригинальная публикация: Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes The LANCET Randomized Trial. JAMA. 2009; 302(11): 1186–1194; Ridker P. M. и другие C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000; 342(12): 836–843.
21. Хаффнер С. и другие Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med, 1998; 339(4): 229–234.
